Arterial stiffness, ambulatory blood pressure monitoring and their association with cardiovascular risk in patients with chronic kidney disease and arterial hypertension.
DOI:
https://doi.org/10.26641/2307-0404.2018.3(part1).142371Keywords:
cardiovascular risk, chronic kidney disease, arterial hypertension, arterial stiffness, endothelial functionAbstract
The aim – to investigate arterial stiffness, daily profile of blood pressure (BP) and their association with cardiovascular risk (CVR) in patients with chronic kidney disease (CKD) and arterial hypertension (AH). 20 patients with CKD (stage 1-2) and AH (stage 1-2) were enrolled in the study (7 males and 13 females, mean age – 55±8,4 years. Depending on CVR risk patients were distributed into three groups: low (<1%), moderate (1-10%) and high risk (≥10%). The highest proportion – patients with moderate risk (50%). Statistically significant association between age and CVR was discovered. Arterial stiffness (measured by pulse pressure and pulse wave velocity) raised with increase of CVR risk. The best values of endothelial function were observed in the group of high risk patients. More than half of patients had non-dipping daily blood pressure profile. Patients in group of high risk presented the highest mean sysolic BP and morning elevation BP.References
[Blood pressure meter BAT41-2. The user's guide to determining the parameters of central aortic pressure and arterial stiffness]. Russian.
Kuryata OV, Garmish IP. [The level of proteinuria and the state of endothelial function in patients with chronic kidney disease combined with subclinical hypothyroidism under the influence of combined antihypertensive therapy]. Medicni perspectivi. 2018;23(2 part 1):19-24. https://doi.org/10.26641/2307-0404.2018.2(part1).129510. Ukrainian.
Kuryata OV, Zabida A, Sirenko O. [Galectin-3, advanced glycated end-products serum levels, endothelial function and cardiac hemodynamics in post infarction heart failure patients with reduced and preserved ejection fraction]. Medicni perspectivi. 2018;23(2 part 1):69-74. https://doi.org/10.26641/2307-0404.2018.2(part1).129519
Wright JT, Jr, Williamson JD, Whelton PK et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-16.
Jablonski KL, Decker E, Perrenoud L, et al. Assessment of Vascular Function in Patients With Chronic Kidney Disease. J. Vis. Exp. (88), e51478, doi: 10.3791/51478
Barry LC, Elizabeth AC. Efficacy and Safety of Nighttime Dosing of Antihypertensives: Review of the Literature and Design of a Pragmatic Clinical Trial. J Clin Hypertens (Greenwich). 2014 February;16(2):115-21. doi: 10.1111/jch.12238.
Major RW, Cheng MRI, Grant RA. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One. 2018 Mar 21;13(3):e0192895. doi: 10.1371/journal.pone.0192895. ECollection 2018.
Centers for Disease Control and Prevention. Age-adjusted prevalence of CKD Stages 1-4 by Gender 1999-2012. Chronic Kidney Disease (CKD) Surveillance Project website. https://nccd.cdc.gov. Accessed December 6, 2016.
O’Brien E, Parati G, Stergiou G et al. European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring. Journal of Hypertension 2013, 31:1731-68. doi: 10.1097/HJH.0b013e328363e964
Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). European Heart Journal. 2012;33:1635-701. doi: 10.1093/eurheartj/ehs092
Mansia G, De Backer G, Dominiczak A. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007;16(3):135-232.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-605.
Julie HI, Kirsten LJ. Exclusion of Patients With Kidney Disease From Cardiovascular Trials. JAMA Intern Med. 2016;176(1):124-5. doi: 10.1001/jamainternmed.2015.6403
Judd E, Calhoun DA. Management of hypertension in CKD: beyond the guidelines. Adv Chronic Kidney 2015 Mar;22(2):116-22. doi: 10.1053/j.ackd.2014.12.001
Greeve SV. Estimated Pulse Wave Velocity Calculated from Age and Mean Arterial Blood Pressure. Pulse (Basel). 2017 Jan;4(4):175-9. Published online 2016 Dec 1. doi: 10.1159/000453073
Csaba EK. Hypertension in chronic kidney disease after the Systolic Blood Pressure Intervention Trial: targets, treatment and current uncertainties. Nephrol Dial Transplant. 2017;32:ii219-23 doi: 10.1093/ndt/gfw269
Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, Najjar SS, Nichols WW, Urbina EM, Weber T. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698-722.
Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018 Feb;15(2):97-105. doi: 10.1038/nrcardio.2017.155. Epub 2017 Oct 12.
Townsend RR. Arterial Stiffness: Recommendations Standardization. Pulse (Basel). 2017 Jan;4(Suppl 1):3-7. doi: 10.1159/000448454
Manuel TV, Srinivasan B, Ehsan N. Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time? Kidney Int Rep. 2016 July;1(2):94-104. doi: 10.1016/j.ekir.2016.05.001
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
